Applied Genetic Technologies Corporation Soared

Applied Genetic Technologies Corporation (AGTC:NASDAQ) rocketted at $0.39, representing a gain of 62.4%. On Mon, Oct 24, 2022, AGTC:NASDAQ touched a New 2-Week High of $0.39. The stock appeared on our News Catalysts scanner on Mon, Oct 24, 2022 at 02:06 PM in the 'MISCELLANEOUS' category. From Mon, Oct 10, 2022, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Tue, Aug 16, 2022 at $0.49 with a volume of 1M+.
About Applied Genetic Technologies Corporation (AGTC:NASDAQ)
Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 62.43%
- Vaxcyte Inc. (PCVX:NASDAQ), 60.35%
- Mullen Automotive Inc. (MULN:NASDAQ), 32.94%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 24.76%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 23.13%
- NOVONIX Limited (NVX:NASDAQ), 22.1%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 20.6%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 18.1%
- uCloudlink Group Inc. (UCL:NASDAQ), 16.96%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 16.7%